Story perspectives
FDA's Acetaminophen Warning Sparks Autism Debate and Backlash
10/5/2025
1 of 1
Story summary
- The U.S. Food and Drug Administration (FDA) issued warning labels for acetaminophen citing a possible autism link, triggering backlash recently.
- President Donald Trump commented on the issue recently.
- Experts say autism diagnoses rise from better recognition, not a true increase.
- A Swedish study of 2.5 million children found little difference in autism rates with in utero acetaminophen exposure.
